Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 15;225(12):2167-2175.
doi: 10.1093/infdis/jiac089.

Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection

Affiliations

Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection

Eugène Kroon et al. J Infect Dis. .

Abstract

Starting antiretroviral therapy (ART) in Fiebig 1 acute HIV infection limits the size of viral reservoirs in lymphoid tissues, but does not impact time to virus rebound during a treatment interruption. To better understand why the reduced reservoir size did not increase the time to rebound we measured the frequency and location of HIV RNA+ cells in lymph nodes from participants in the RV254 acute infection cohort. HIV RNA+ cells were detected more frequently and in greater numbers when ART was initiated in Fiebig 1 compared to later Fiebig stages and were localized to the T-cell zone compared to the B-cell follicle with treatment in later Fiebig stages. Variability of virus production in people treated during acute infection suggests that the balance between virus-producing cells and the immune response to clear infected cells rapidly evolves during the earliest stages of infection. Clinical Trials Registration: NCT02919306.

Keywords: HIV reservoir; acute HIV infection; antiretroviral therapy; in situ hybridization; lymphoid tissues.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Measures of HIV in lymph nodes of the untreated group. HIV RNA in situ hybridization and quantitative image analysis were used to measure the frequency of HIV vRNA+ cells/g lymphoid tissue in those biopsied immediately at the time of diagnosis (A) expressed as vRNA+ cells/g and (B) as vRNA+ cells/million CD4 T cells. C, The relationship between log frequency of vRNA+ cells/g and the log plasma viral load is significant (R2 = 0.301, P < .001, linear regression). Abbreviations: F, Fiebig; vRNA+, virus RNA positive.
Figure 2.
Figure 2.
The frequency of vRNA+ cell was significantly higher in people treated during Fiebig 1 than other Fiebig stages. A, The frequency of vRNA+ cells/g of LN tissue in Fiebig 1 compared to the frequency from LN in participants from Fiebig stages 2–5 (P = .03). A multivariable linear generalized estimating equation regression model with independent working correlation was used to compare log base 10 transformed vRNA+ cells/g (measured by RNAscope 2.5) during ART between Fiebig groups (Fiebig 1 vs >1), after adjusting for time on ART and age at biopsy (Supplementary Table 5). B, The frequency of cells/g was converted to frequency per million CD4 T cells in the LN (P = .04) and a similarly constructed model was used for comparing log base 10 transformed vRNA+ cells/million CD4 T cells between Fiebig groups. Results from models unadjusted for other covariates (age at biopsy and time on ART) are also presented as a sensitivity analysis (Supplementary Table 5). Abbreviations: ART, antiretroviral therapy; F, Fiebig; LN, lymph node; vRNA+, virus RNA positive.
Figure 3.
Figure 3.
Representative images of lymph nodes from Fiebig 1 at the time of diagnosis (A) and after ART (B) and from Fiebig 3 at diagnosis (C) and after ART (D). A, Scale bar 50 µm. B, C, and D, scale bar 100 µm. Arrows show vRNA+ cells. Abbreviations: ART, antiretroviral therapy; vRNA+, virus RNA positive.
Figure 4.
Figure 4.
The percent of vRNA+ cells found in B-cell follicles during ART at Fiebig 1–2, Fiebig 3–5, and in a group of HIV-infected people who started ART in chronic HIV infection (data generated from archived tissues). Adjusted P value = .01 for comparing Fiebig 1–2 to chronic infection. Abbreviations: ART, antiretroviral therapy; vRNA+, virus RNA positive.

Similar articles

Cited by

References

    1. Embretson J, Zupancic M, Beneke J, et al. . Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. PNAS 1993; 90:357–61. - PMC - PubMed
    1. Embretson J, Zupancic M, Ribas JL, et al. . Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS [see comments]. Nature 1993; 362:359–62. - PubMed
    1. Reinhart TA, Rogan MJ, Huddleston D, Rausch DM, Eiden LE, Haase AT.. Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS. J Infect Dis 1997; 176:1198–208. - PubMed
    1. Zhang Z, Schuler T, Zupancic M, et al. . Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999; 286:1353–7. - PubMed
    1. Fletcher CV, Staskus K, Wietgrefe SW, et al. . Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci USA 2014; 111:2307–12. - PMC - PubMed

Publication types

MeSH terms

Associated data